Spermatinamine, the first natural product inhibitor of isoprenylcysteine carboxyl methyltransferase, a new cancer target

Bioorg Med Chem Lett. 2007 Dec 15;17(24):6860-3. doi: 10.1016/j.bmcl.2007.10.021. Epub 2007 Oct 16.

Abstract

Isoprenylcysteine methyltransferase (Icmt) catalyzes the carboxyl methylation of oncogenic proteins in the final step of a series of post-translational modifications. The inhibition of Icmt provides an attractive and novel anticancer target. A natural product high-throughput screening campaign was conducted to discover inhibitors of Icmt. The Australian marine sponge, Pseudoceratina sp., yielded spermatinamine, a novel alkaloid with a bromotyrosyl-spermine-bromotyrosyl sequence, as the bioactive constituent. Its structure was determined by 1D and 2D NMR spectroscopy. Spermatinamine is the first natural product inhibitor of Icmt.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / toxicity*
  • Biological Products / chemistry*
  • Biological Products / toxicity*
  • Enzyme Inhibitors / chemistry
  • Enzyme Inhibitors / toxicity
  • Magnetic Resonance Spectroscopy
  • Molecular Structure
  • Neoplasms / enzymology*
  • Neoplasms / pathology
  • Protein Methyltransferases / antagonists & inhibitors*
  • Protein Methyltransferases / metabolism
  • Spermine / analogs & derivatives*
  • Spermine / chemistry
  • Spermine / toxicity
  • Tyrosine / analogs & derivatives*
  • Tyrosine / chemistry
  • Tyrosine / toxicity

Substances

  • Antineoplastic Agents
  • Biological Products
  • Enzyme Inhibitors
  • spermatinamine
  • Spermine
  • Tyrosine
  • Protein Methyltransferases
  • protein-S-isoprenylcysteine O-methyltransferase